ATE543806T1 - 5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung - Google Patents
5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellungInfo
- Publication number
- ATE543806T1 ATE543806T1 AT08766671T AT08766671T ATE543806T1 AT E543806 T1 ATE543806 T1 AT E543806T1 AT 08766671 T AT08766671 T AT 08766671T AT 08766671 T AT08766671 T AT 08766671T AT E543806 T1 ATE543806 T1 AT E543806T1
- Authority
- AT
- Austria
- Prior art keywords
- thiadiazoles
- dihydroxyphenyl
- aryl
- substituted
- inhibitors
- Prior art date
Links
- 101710113864 Heat shock protein 90 Proteins 0.000 title 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 title 1
- 108010006519 Molecular Chaperones Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 150000004867 thiadiazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LT2008035A LT5623B (lt) | 2008-04-30 | 2008-04-30 | 5-aril-4-(5-pakeistieji 2,4-dihidroksifenil)-1,2,3-tiadiazolai kaip hsp90 šaperono slopikliai ir tarpiniai junginiai jiems gauti |
| PCT/LT2008/000003 WO2009134110A1 (en) | 2008-04-30 | 2008-06-18 | 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543806T1 true ATE543806T1 (de) | 2012-02-15 |
Family
ID=39682765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08766671T ATE543806T1 (de) | 2008-04-30 | 2008-06-18 | 5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8314132B2 (de) |
| EP (1) | EP2268626B1 (de) |
| AT (1) | ATE543806T1 (de) |
| LT (1) | LT5623B (de) |
| WO (1) | WO2009134110A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02144B (me) | 2010-12-20 | 2015-10-20 | Sigma Tau Res Switzerland Sa | Jedinjenja aril triazola sa antitumorskom aktivnošću |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2559689B1 (fr) | 1984-02-22 | 1987-05-15 | Siderurgie Fse Inst Rech | Laminoir du type planetaire universel pour produits longs |
| NZ331062A (en) | 1996-10-25 | 2000-05-26 | Kyowa Hakko Kogyo Company Ltd | Radicicol derivatives or pharmacologically acceptable salts which show tyrosine kinase inhibition activity and have antitumor effects |
| US7439359B2 (en) | 2000-11-02 | 2008-10-21 | Sloan-Kettering Institute For Cancer Research | Small molecule compositions for binding to hsp90 |
| EP1440072A4 (de) | 2001-10-30 | 2005-02-02 | Conforma Therapeutic Corp | Purinanaloga mit hsp90-inhibierender wirkung |
| GB0228417D0 (en) | 2002-12-05 | 2003-01-08 | Cancer Rec Tech Ltd | Pyrazole compounds |
| KR101166749B1 (ko) * | 2003-02-11 | 2012-07-27 | 베르날리스(캠브리지)리미티드 | 열쇼크 단백질 저해제로서의 이소옥사졸 화합물 |
| GB0309637D0 (en) | 2003-04-28 | 2003-06-04 | Cancer Rec Tech Ltd | Pyrazole compounds |
| GB0315111D0 (en) | 2003-06-27 | 2003-07-30 | Cancer Rec Tech Ltd | Substituted 5-membered ring compounds and their use |
| NZ546611A (en) | 2003-09-18 | 2010-02-26 | Conforma Therapeutics Corp | Novel heterocyclic compounds as HSP90-inhibitors |
| JP2005225787A (ja) | 2004-02-12 | 2005-08-25 | Nippon Kayaku Co Ltd | Hsp90阻害剤 |
| DE102004039280A1 (de) * | 2004-08-13 | 2006-02-23 | Merck Patent Gmbh | 1,5-Diphenyl-pyrazole |
| FR2880540B1 (fr) | 2005-01-13 | 2008-07-11 | Aventis Pharma Sa | Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90 |
| BRPI0609509A2 (pt) | 2005-03-30 | 2010-04-13 | Conforma Therapeutics Corp | composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável |
| CN101193862B (zh) | 2005-04-13 | 2013-08-21 | 阿斯特克斯治疗有限公司 | 羟基苯甲酰胺衍生物和其作为hsp90抑制剂的用途 |
| US20070027150A1 (en) | 2005-04-14 | 2007-02-01 | Bellamacina Cornelia R | 2-Amino-quinazolin-5-ones |
| JP2006306755A (ja) | 2005-04-27 | 2006-11-09 | Nippon Kayaku Co Ltd | 新規なピラゾール誘導体とそれを有効成分とするhsp90阻害剤 |
| WO2007021966A1 (en) | 2005-08-12 | 2007-02-22 | Synta Pharmaceuticals Corp. | Pyrazole compounds that modulate hsp90 activity |
| CA2618628C (en) | 2005-08-18 | 2014-11-18 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
| DE102006023337A1 (de) * | 2006-05-18 | 2007-11-22 | Merck Patent Gmbh | Triazolderivate II |
| TW200806637A (en) | 2006-05-25 | 2008-02-01 | Synta Pharmaceuticals Corp | Synthesis of triazole compounds that modulate HSP90 activity |
| CA2820957A1 (en) | 2006-05-26 | 2007-12-06 | Laboratory Corporation Of America Holdings | Liquid chromatography with tandem mass spectrometry of estrone, estradiol and free thyroxine |
| CN1865252A (zh) * | 2006-06-19 | 2006-11-22 | 中国科学院上海药物研究所 | 4,5-二取代苯基-1,2,3-噻二唑类衍生物,及其制备方法和用途 |
| CA2659425C (en) | 2006-08-17 | 2017-06-20 | Synta Pharmaceuticals Corp. | Triazole compounds that modulate hsp90 activity |
-
2008
- 2008-04-30 LT LT2008035A patent/LT5623B/lt not_active IP Right Cessation
- 2008-06-18 EP EP08766671A patent/EP2268626B1/de not_active Not-in-force
- 2008-06-18 AT AT08766671T patent/ATE543806T1/de active
- 2008-06-18 WO PCT/LT2008/000003 patent/WO2009134110A1/en not_active Ceased
- 2008-06-18 US US12/990,551 patent/US8314132B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2268626B1 (de) | 2012-02-01 |
| WO2009134110A1 (en) | 2009-11-05 |
| EP2268626A1 (de) | 2011-01-05 |
| US20110046387A1 (en) | 2011-02-24 |
| US8314132B2 (en) | 2012-11-20 |
| LT2008035A (en) | 2009-11-25 |
| LT5623B (lt) | 2010-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| UA97834C2 (ru) | Производные сульфониламида для лечения анормального роста клеток | |
| IN2012DN01233A (de) | ||
| EA200901133A1 (ru) | Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение | |
| ATE482210T1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
| NI200700064A (es) | Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos. | |
| EA200701799A1 (ru) | Транс-каротиноиды, синтез указанных каротиноидов, получение композиций и их применение | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
| MX2013008478A (es) | 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2). | |
| SA522431498B1 (ar) | مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا | |
| ATE487720T1 (de) | 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer | |
| MX2013008213A (es) | N-[3-(5-amino-3,3a,7,7a-tetrahidro-1h-2,4-dioxa-6-aza-inden-7-il) -fenil]-amidas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
| BRPI0920355B8 (pt) | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina | |
| IL206514A (en) | History of triazole oxadiazole, their preparation and their pharmaceutical preparations | |
| UA107349C2 (en) | Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug | |
| DE602004030017D1 (de) | Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer | |
| TW200716568A (en) | 1H-quinazoline-2,4-diones | |
| ATE524486T1 (de) | Lys-thr-dipeptide und deren verwendung | |
| MX2011013130A (es) | Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos. | |
| JOP20240127A1 (ar) | مركبات ثنائي آزا سبيرو بها استبدال بكربونيل واستخدامها | |
| TW200745122A (en) | New compounds I | |
| EP1817312A4 (de) | Makrozyklische aminiopyridyl-beta-sekretase-hemmer zur behandlung von morbus alzheimer | |
| ATE517900T1 (de) | Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung | |
| MA32062B1 (fr) | Sels de triazolium comme inhibiteurs de par1, leur production et leur utilisation comme médicaments |